SCHEMBL18539204

SCHEMBL18539204

O=C(O)c1ccccc1-c1cccc2c(-c3ccccc3C(=O)O)cccc12

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR4A1 P22736 1/20 0.61
▸ NR4A2 P43354 1/20 0.61
▸ NR4A3 Q92570 1/20 0.61
▸ ALDH1A1 P00352 5/20 0.59
▸ ALOX15 P16050 1/20 0.59
▸ MYC P01106 1/20 0.59
▸ CYP3A4 P08684 1/20 0.57
▸ CYP2C9 P11712 1/20 0.57
▸ ALOX12 P18054 1/20 0.57
▸ HNF4A P41235 1/20 0.55
▸ HSD17B10 Q99714 1/20 0.54
▸ L3MBTL1 Q9Y468 2/20 0.53
▸ LMNA P02545 2/20 0.53
▸ CDC25B P30305 1/20 0.53
▸ MAPT P10636 1/20 0.53
▸ GAA P10253 1/20 0.53
▸ FOLH1 Q04609 2/20 0.53
▸ SOS1 Q07889 1/20 0.50
▸ KDM4E B2RXH2 1/20 0.50
▸ CA12 O43570 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29908923 0.95 ALDH1A1 (0.59) NR4A1NR4A2NR4A3ALDH1A1ALOX15
SCHEMBL1641502 0.92 NR4A1 (0.70) NR4A1NR4A2NR4A3ALDH1A1ALOX15
SCHEMBL36145 0.90 ALDH1A1 (0.72) ALDH1A1ALOX15MYCCYP3A4CYP2C9
SCHEMBL30028907 0.90 ALDH1A1 (0.72) ALDH1A1ALOX15MYCCYP3A4CYP2C9
Ammonia Solution, Strong SCHEMBL11705221 0.90 NR4A1 (0.68) NR4A1NR4A2NR4A3ALDH1A1ALOX15
SCHEMBL2179040 0.88 HSD17B10 (0.53) NR4A1NR4A2NR4A3ALDH1A1ALOX15
SCHEMBL1324771 0.88 NR4A1 (0.64) NR4A1NR4A2NR4A3ALDH1A1ALOX15
SCHEMBL30720582 0.88 NR4A1 (0.64) NR4A1NR4A2NR4A3ALDH1A1ALOX15
SCHEMBL2830888 0.87 ALDH1A1 (0.68) ALDH1A1ALOX15MYCCYP3A4CYP2C9
Hydrochloric Acid SCHEMBL7579852 0.87 ALDH1A1 (0.68) ALDH1A1ALOX15MYCCYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10005796-B2 Substituted angular bistetracenes and substituted angular bisoligoacenes and electronic devices made with same UNIVERSITY OF MASSACHUSETTS (US) 2018-06-26 — — US disclosed
US-20170050991-A1 SUBSTITUTED ANGULAR BISTETRACENES AND SUBSTITUTED ANGULAR BISOLIGOACENES AND ELECTRONIC DEVICES MADE WITH SAME UNIVERSITY OF MASSACHUSETTS 2017-02-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170050991-A1 SUBSTITUTED ANGULAR BISTETRACENES AND SUBSTITUTED ANGULAR BISOLIGOACENES AND ELECTRONIC DEVICES MADE WITH SAME AHR, FARS2, PARG NR4A1 920/4885NR4A2 1002/4885NR4A3 647/4885
US-10005796-B2 Substituted angular bistetracenes and substituted angular bisoligoacenes and electronic devices made with same AHR, FARS2, PARG NR4A1 920/4885NR4A2 1002/4885NR4A3 647/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback